Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines.
about
Adverse Psychiatric Effects Associated with Herbal Weight-Loss ProductsInteractions between CYP3A4 and Dietary PolyphenolsTraditional Chinese medicine therapy decreases the pneumonia risk in patients with dementiaMedicinally Used Asarum Species: High-Resolution LC-MS Analysis of Aristolochic Acid Analogs and In vitro Toxicity Screening in HK-2 Cells.Plasma metabonomics study on toxicity biomarker in rats treated with Euphorbia fischeriana based on LC-MS.An overview on adverse drug reactions to traditional Chinese medicines.Encapsulation of Aconitine in Self-Assembled Licorice Protein Nanoparticles Reduces the Toxicity In Vivo.The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safetyIn Vivo Evaluation of Galla chinensis Solution in the Topical Treatment of Dermatophytosis.Yellow Oleander Seed, or "Codo de Fraile" (Thevetia spp.): A Review of Its Potential Toxicity as a Purported Weight-Loss Supplement.Adverse drug reactions in some African herbal medicine: literature review and stakeholders' interview.Using SSR-HRM to Identify Closely Related Species in Herbal Medicine Products: A Case Study on Licorice.Natural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host MicrobiomeNew Contributions to Asarum Powder on Immunology Related Toxicity Effects in LungIsolation and characterization of nanometre aggregates from a Bai-Hu-Tang decoction and their antipyretic effectCommon phyto-remedies used against cardiovascular diseases and their potential to induce adverse events in cardiovascular patients
P2860
Q26784276-FF7C5F48-F819-4BED-924E-AC4E7154E6F3Q26800893-BEE29A21-040B-4594-8E79-2D293E9AF548Q33595480-9C54EF1F-7545-466F-9BA6-C28E6195B4ABQ33710924-57C40631-F281-40BF-AFA7-2EE6A719243AQ35917449-5E79D52B-3F9E-4BCD-B9E1-9E777E270AEBQ36125530-F61FBEEC-0EE3-410D-B434-E775DAD63485Q36300142-E605A5C3-F724-40E7-B9D1-273142B42D25Q37459724-562D50DD-E953-4373-AFEB-26016EC9E402Q47106470-E454779C-DE60-41EA-8023-2267D15F3573Q47185292-B77A8FB3-AC59-4B09-8157-2E3CFBBDD2D2Q51059237-D4DEF3A3-382C-4224-BE5A-74BBF31C5F62Q54961670-5869E066-7D26-4BA5-A82F-8ED773D64E5BQ58703927-7EE297F9-1016-46CB-9DA8-31C736DCD9E0Q58769995-B05B0A8C-3518-4D53-AF7E-304BDD8745D9Q58778246-30512CEE-0B1A-4042-A790-E24A5EB80409Q58870438-982444EF-2605-4EB9-9C0F-BEBEAC410887
P2860
Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines.
@en
type
label
Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines.
@en
prefLabel
Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines.
@en
P2093
P1476
Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines
@en
P2093
Ellie J Y Kim
George Q Li
Jianping Liu
Johnson Q Huang
Josiah Poon
Kelvin Chan
Meicun Yao
Sui-Lin Mo
P356
10.1016/J.JEP.2012.12.027
P577
2012-12-31T00:00:00Z